CAPLIN POINT LABORATORIES LTD. - 524742 - Corporate Action-Board approves Dividend
The Board had approved interim dividend for the year ended 31-03-2024. The details of the same is enclosed herewith16-05-2024
CAPLIN POINT LABORATORIES LTD. - 524742 - Corporate Action-Board approves Dividend
The Board had approved interim dividend for the year ended 31-03-2024. The details of the same is enclosed herewithCAPLIN POINT LABORATORIES LTD. - 524742 - Results For The Quarter And Year Ended March 31, 2024
The results for the quarter and year ended March 31, 2024 along with the details of interim divided is attached herewithCAPLIN POINT LABORATORIES LTD. - 524742 - Board Meeting Outcome for Financial Results Outcome
Financial Results for the quarter and year ended March 31, 2024 is enclosedCAPLIN POINT LABORATORIES LTD. - 524742 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Details of loss of share certificates are attached herewithCAPLIN POINT LABORATORIES LTD. - 524742 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Q4 post-results conference call invite is enclosed herewith.CAPLIN POINT LABORATORIES LTD. - 524742 - Board Meeting Intimation for Financial Results And Declaration Of Interim Dividend, If Approved By The Board.
CAPLIN POINT LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 16/05/2024 ,inter alia, to consider and approve Annual audited financial results of the Company for the year ended March 31, 2024 (both standalone & consolidated) and declaration of Interim Dividend, if any, for the FY 2023-24 and fixation of record date for determining the eligibility of shareholders.CAPLIN POINT LABORATORIES LTD. - 524742 - General Announcements
Please find the attached Press Release on Grant of INVIMA ApprovalCAPLIN POINT LABORATORIES LTD. - 524742 - Compliance Certificate In Terms Of Regulation 40 (10) Of The SEBI Listing Regulations
The Compliance Certificate issued by PCS for the year ended March 31, 2024 is attached herewithCaplin Point: What should investors do
Steady expansion in products and markets to play out in next two yearsCAPLIN POINT LABORATORIES LTD. - 524742 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Details of loss of share certificates are attached herewith